grepcent / static financial knowledge base

Informational only - not investment advice.

Money & trade macro thread

Money-stock and goods-and-services trade balance indicators from Federal Reserve, Census, and BEA public data.

As of: 2026-05-08. Related topic page: /skills/money-trade.html.

This page is a data-driven assembly of existing grepcent indicators, SIC crosswalks, SEC company financials, and sanitized SEC MD&A text. The mapped sectors are grepcent descriptive editorial mappings, not forecasts, recommendations, or investment advice. Company inclusion is mechanical - largest by revenue in the mapped SIC sectors - and is not a recommendation, endorsement, or an assessment of any company's exposure to this theme.

Sector mapping is coarse (SIC level) and does not imply a company's business is driven by this theme; keyword matches are literal and may be incidental - read the linked filing for context.

Macro Side

IndicatorLatest ReadingUnitsAs OfSource
M2SL - M222804.5Billions of Dollars2026-04-01FRED source
BOPGSTB - U.S. International Trade in Goods and Services: Balance-55881Millions of Dollars2026-04-01FRED source

Mapped SIC Sectors

Mapped from the existing topic crosswalk, refined where needed to SIC major-group scope for company selection.

Largest Companies in Mapped Sectors (by revenue)

Companies are selected from the mapped SIC sectors and sorted by latest reported annual revenue (from SEC companyfacts). Missing metrics are left blank. MD&A signals are keyword matches against the sanitized latest 10-K MD&A text. Keywords scanned: money supply, trade balance, exports, imports, foreign exchange, tariff.

CompanyRevenueFYNet MarginOperating MarginRevenue GrowthMD&A MentionsVerbatim MD&A Excerpt
UNH - UNITEDHEALTH GROUP INC447,567,000,00020252.69%4.24%11.81%

No keyword match found in emitted latest 10-K MD&A.

AAPL - Apple Inc.416,161,000,000202526.92%31.97%6.43%imports, tariff
Beginning in the second quarter of 2025, new U.S. Tariffs were announced, including additional tariffs on imports from China, India, Japan, South Korea, Taiwan, Vietnam and the EU, among others.

Verbatim sentence from AAPL latest 10-K MD&A, filed 2025-10-31; 0000320193-25-000079.

MCK - MCKESSON CORP403,430,000,00020261.18%1.54%12.36%

No keyword match found in emitted latest 10-K MD&A.

BRK-B - BERKSHIRE HATHAWAY INC371,444,000,000202518.03%0.00%exports, imports, tariff
The volumes increase was primarily due to higher intermodal shipments resulting from higher West Coast imports and a new intermodal customer, and an increase in automotive vehicle volumes.

Verbatim sentence from BRK-B latest 10-K MD&A, filed 2026-03-02; 0001193125-26-083899.

XOM - EXXON MOBIL CORP332,238,000,00020258.68%-4.96%imports, foreign exchange
During 2025, the U.S. announced a variety of trade-related actions, including the imposition of tariffs on imports from several countries.

Verbatim sentence from XOM latest 10-K MD&A, filed 2026-02-18; 0000034088-26-000045.

COR - Cencora, Inc.321,332,819,00020250.48%0.82%9.31%foreign exchange
Our largest exposure to foreign exchange rates exists primarily with the U.K. Pound Sterling, the Euro, the Turkish Lira, the Brazilian Real, and the Canadian Dollar.

Verbatim sentence from COR latest 10-K MD&A, filed 2025-11-25; 0001140859-25-000131.

CI - Cigna Group274,900,000,00020252.17%3.35%11.24%

No keyword match found in emitted latest 10-K MD&A.

CAH - CARDINAL HEALTH INC222,578,000,00020250.70%1.02%-1.87%tariff
We have taken action to reduce the potential impact of tariffs on our costs; however, at this time, the countries which will be subject to tariffs and the tariff rate that may be imposed on each country is uncertain and dynamic and we do not expect to be able to establish alternative sources of supply or otherwise mitigate the potential impact of tariffs on all of the products that we source, manufacture, or distribute.

Verbatim sentence from CAH latest 10-K MD&A, filed 2025-08-12; 0000721371-25-000079.

NVDA - NVIDIA CORP215,938,000,000202655.60%60.38%65.47%exports, imports, tariff
In April 2025, the USG informed us that a license is required for exports of our H20 product into the China market.

Verbatim sentence from NVDA latest 10-K MD&A, filed 2026-02-25; 0001045810-26-000021.

ELV - Elevance Health, Inc.199,125,000,00020252.84%3.62%12.49%foreign exchange

No short unambiguous sentence excerpt emitted; see full company MD&A.

CNC - CENTENE CORP194,777,000,0002025-3.43%-3.91%19.44%

No keyword match found in emitted latest 10-K MD&A.

CVX - CHEVRON CORP189,031,000,00020256.51%-6.79%exports, imports, foreign exchange, tariff
In 2025, the U.S. announced the imposition of various changing tariffs on imports from our trade partners.

Verbatim sentence from CVX latest 10-K MD&A, filed 2026-02-24; 0000093410-26-000078.

F - FORD MOTOR CO187,267,000,0002025-4.36%-4.90%1.23%foreign exchange, tariff
To the extent governments in various regions implement or intensify restrictions or barriers to trade, such as tariff or non-tariff barriers, export controls, currency manipulation, or policies that otherwise favor domestic companies, there can be a significant negative impact on manufacturers based in other markets.

Verbatim sentence from F latest 10-K MD&A, filed 2026-02-11; 0000037996-26-000015.

GM - General Motors Co185,019,000,00020251.46%1.57%-1.29%imports, foreign exchange, tariff
Over the course of 2025, the U.S. and other governments implemented new tariffs relevant to GM and its suppliers, including tariffs on vehicles and parts imported into the U.S. The tariff environment remains highly dynamic, and the specific tariffs applicable to goods imported by GM and its suppliers continue to evolve, including with respect to imports under the U.S.-Mexico-Canada Agreement and other trade agreements.

Verbatim sentence from GM latest 10-K MD&A, filed 2026-01-27; 0001467858-26-000013.

JPM - JPMORGAN CHASE & CO182,447,000,000202531.27%2.75%foreign exchange
Foreign exchange risk is transferred from the LOBs and Other Corporate to Treasury and CIO for certain revenues and expenses.

Verbatim sentence from JPM latest 10-K MD&A, filed 2026-02-13; 0001628280-26-008131.

Informational only - not investment advice.